Results 331 to 340 of about 829,320 (360)
Some of the next articles are maybe not open access.
The Potential for Adjuvant Radiotherapy in Choroidal Melanoma
Archives of Ophthalmology, 1982Controversy exists regarding the efficacy of enucleation in the management of choroidal melanoma. The effect of any form of ocular therapy on the prevalence of choroidal melanoma metastases is unknown. In a number of other systemic tumors, preoperative irradiation may lessen the occurrence of widespread disease.
Theodore L. Phillips, Devron H. Char
openaire +3 more sources
Retinoblastoma: The case for radiotherapy and for adjuvant chemotherapy
Cancer, 1980The results of treatment for 39 consecutive children with retinoblastoma that was diagnosed between 1951 and 1978 were analyzed. Failure to achieve local control within the eye and the development of metastatic disease occurred in seven patients. These patients are considered individually.
J.M. Little +5 more
openaire +3 more sources
Radiotherapy in the Adjuvant Management of Pancreatic Adenocarcinoma
Seminars in Oncology, 2005There is sound rationale for the use of radiotherapy (RT) as part of adjuvant treatment in patients with resectable pancreatic adenocarcinoma. Most available data from randomized clinical trials and large reported experiences with RT indicate that chemoradiotherapy (chemoRT) improves outcome over surgery alone in this setting. The recent European Study
openaire +3 more sources
Adjuvant and Definitive Radiotherapy for Adrenocortical Carcinoma
International Journal of Radiation Oncology*Biology*Physics, 2011To evaluate the impact of both adjuvant and definitive radiotherapy on local control of adrenocortical carcinoma.Outcomes were analyzed from 58 patients with 64 instances of treatment for adrenocortical carcinoma at the University of Michigan's Multidisciplinary Adrenal Cancer Clinic.
Mary Feng +5 more
openaire +3 more sources
Long-Term Costs of Adjuvant Radiotherapy
1982Before discussing long-term costs it is worthwhile to define adjuvant radiotherapy. We cannot surely define as adjuvant the irradiation that follows a nonradical operation, because such treatment is compulsory and long-term costs are the price of recovery. We cannot talk about adjuvant treatment also after radical but limited surgery, such as a partial
D. Sigurtà, F. Volterrani
openaire +3 more sources
Postoperative Adjuvant Radiotherapy – Standard of Care?
2008Within 5 years following radical prostatectomy, between 15 and 60% of patients with pT3 prostate carcinomas show an increasing prostate-specific antigen (PSA) level as a sign of local and/or systemic tumor progression. Apart from a large number of retrospective investigations, results are available from 3 randomized studies.For pT3 prostate carcinomas,
Thomas Wiegel, Dirk Bottke
openaire +3 more sources
Randomized Trials for Adjuvant Radiotherapy
2014The optimal management of patients with adverse clinical and pathologic features concerning the risk of a biochemical recurrence after radical prostatectomy is still under discussion. The two treatment approaches for patients with undetectable PSA are immediate adjuvant radiotherapy or observation followed by early salvage radiation therapy in case of ...
Dirk Bottke, Thomas Wiegel
openaire +2 more sources